These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 23229173

  • 1. Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC.
    Salvi A, Abeni E, Portolani N, Barlati S, De Petro G.
    Int J Oncol; 2013 Feb; 42(2):391-402. PubMed ID: 23229173
    [Abstract] [Full Text] [Related]

  • 2. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH, Zayed N, Riad NM, Tamim HH, Shahin RMH, Labib DA, ELsheikh SM, Moneim RA, Yosry A, Khalifa RH.
    Virus Res; 2018 Aug 15; 255():77-84. PubMed ID: 30003924
    [Abstract] [Full Text] [Related]

  • 3. Identifying Differentially Expressed MicroRNAs Between Cirrhotic and Non-Cirrhotic Hepatocellular Carcinoma and Exploring Their Functions Using Bioinformatic Analysis.
    Mei Y, You Y, Xia J, Gong JP, Wang YB.
    Cell Physiol Biochem; 2018 Aug 15; 48(4):1443-1456. PubMed ID: 30064138
    [Abstract] [Full Text] [Related]

  • 4. Effects of miR-193a and sorafenib on hepatocellular carcinoma cells.
    Salvi A, Conde I, Abeni E, Arici B, Grossi I, Specchia C, Portolani N, Barlati S, De Petro G.
    Mol Cancer; 2013 Dec 13; 12():162. PubMed ID: 24330766
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
    Jin Y, Wong YS, Goh BKP, Chan CY, Cheow PC, Chow PKH, Lim TKH, Goh GBB, Krishnamoorthy TL, Kumar R, Ng TP, Chong SS, Tan HH, Chung AYF, Ooi LLPJ, Chang JPE, Tan CK, Lee CGL.
    Sci Rep; 2019 Jul 18; 9(1):10464. PubMed ID: 31320713
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
    Elemeery MN, Mohamed MA, Madkour MA, Shamseya MM, Issa NM, Badr AN, Ghareeb DA, Pan CH.
    World J Gastroenterol; 2019 Nov 14; 25(42):6322-6341. PubMed ID: 31754293
    [Abstract] [Full Text] [Related]

  • 8. Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.
    Fornari F, Ferracin M, Trerè D, Milazzo M, Marinelli S, Galassi M, Venerandi L, Pollutri D, Patrizi C, Borghi A, Foschi FG, Stefanini GF, Negrini M, Bolondi L, Gramantieri L.
    PLoS One; 2015 Nov 14; 10(10):e0141448. PubMed ID: 26509672
    [Abstract] [Full Text] [Related]

  • 9. Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma.
    Wojcicka A, Swierniak M, Kornasiewicz O, Gierlikowski W, Maciag M, Kolanowska M, Kotlarek M, Gornicka B, Koperski L, Niewinski G, Krawczyk M, Jazdzewski K.
    Int J Biochem Cell Biol; 2014 Aug 14; 53():208-17. PubMed ID: 24875649
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma.
    Lendvai G, Szekerczés T, Gyöngyösi B, Schlachter K, Kontsek E, Pesti A, Patonai A, Werling K, Kovalszky I, Schaff Z, Kiss A.
    Pathol Oncol Res; 2019 Jul 14; 25(3):1103-1109. PubMed ID: 30411298
    [Abstract] [Full Text] [Related]

  • 11. miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.
    Fittipaldi S, Vasuri F, Bonora S, Degiovanni A, Santandrea G, Cucchetti A, Gramantieri L, Bolondi L, D'Errico A.
    Dig Dis Sci; 2017 Sep 14; 62(9):2397-2407. PubMed ID: 28639131
    [Abstract] [Full Text] [Related]

  • 12. Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients.
    Ashmawy AM, Elgeshy KM, Abdel Salam ET, Ghareeb M, Kobaisi MH, Amin HAA, Sharawy SK, Abdel Wahab AHA.
    Arab J Gastroenterol; 2017 Sep 14; 18(3):144-150. PubMed ID: 28958640
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-224 Expression and Polymorphism Predict the Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Liver Resection.
    Wu C, Wang X, Zhang J, Tang G, Xu Y, Lu C, Li Y.
    Clin Lab; 2019 Jun 01; 65(6):. PubMed ID: 31232017
    [Abstract] [Full Text] [Related]

  • 14. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L, Cai X.
    Diagn Pathol; 2014 Dec 31; 9():1000. PubMed ID: 25552204
    [Abstract] [Full Text] [Related]

  • 15. Candidate lncRNA-miRNA-mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis.
    Zhang R, Jiang YY, Xiao K, Huang XQ, Wang J, Chen SY.
    J Cancer Res Clin Oncol; 2020 Jan 31; 146(1):87-96. PubMed ID: 31758243
    [Abstract] [Full Text] [Related]

  • 16. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W, Chen J, Ding B, Chen D, Zheng H, Jiang D, Xu L, Bao C, Cao G, Fan W.
    J Transl Med; 2018 Sep 29; 16(1):266. PubMed ID: 30268144
    [Abstract] [Full Text] [Related]

  • 17. Correlation of microRNA-16, microRNA-21 and microRNA-101 expression with cyclooxygenase-2 expression and angiogenic factors in cirrhotic and noncirrhotic human hepatocellular carcinoma.
    Zeng W, van den Berg A, Huitema S, Gouw AS, Molema G, de Jong KP.
    PLoS One; 2014 Sep 29; 9(4):e95826. PubMed ID: 24759835
    [Abstract] [Full Text] [Related]

  • 18. Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.
    Liu X, Wang SK, Zhang K, Zhang H, Pan Q, Liu Z, Pan H, Xue L, Yen Y, Chu PG.
    Carcinogenesis; 2015 Feb 29; 36(2):232-42. PubMed ID: 25542894
    [Abstract] [Full Text] [Related]

  • 19. miR-27a as an oncogenic microRNA of hepatitis B virus- related hepatocellular carcinoma.
    Wu XJ, Li Y, Liu D, Zhao LD, Bai B, Xue MH.
    Asian Pac J Cancer Prev; 2013 Feb 29; 14(2):885-9. PubMed ID: 23621256
    [Abstract] [Full Text] [Related]

  • 20. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S, Bhowmik S, Majumdar S, Goswami A, Chakraborty J, Gupta S, Aggarwal S, Ray S, Chatterjee R, Bhattacharyya S, Dutta M, Datta S, Chowdhury A, Dhali GK, Banerjee S.
    Int J Cancer; 2020 Nov 15; 147(10):2934-2947. PubMed ID: 32441313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.